Partner closely with Commercial Therapeutics, US Market Access, Global Commercial Development, Finance, Government Affairs, and Legal to understand and dissect IRA’s potential effects on individual brands and pipeline assets
Be the subject matter expert for therapeutic area leaders, Integrated Brand Teams (IBTs), and Asset Strategy Teams (ASTs) on the implications and timelines of IRA implementation and its long-term impact
Develop and lead a structured framework for the ongoing evaluation and risk assessment of on-market and pipeline assets, collaborating with IBTs and ASTs
Identify and prioritize risks posed by the IRA over the Long Range Plan (LRP) for each asset and facilitate cross-functional risk-navigating teams to propose and drive effective mitigation strategies
Contribute to portfolio-wide risk stratification and segmentation, enabling AbbVie to focus resources and innovation on areas of greatest need and potential impact
Support organizational innovation by driving solutions that minimize IRA risk and maximize opportunity for patients, AbbVie, and the broader industry

Bachelor's degree in business or related discipline
Master’s degree highly desirable
12+ years of progressive experience in highly regulated commercial business; pharmaceutical or healthcare industry strongly preferred
Advanced degree in life sciences, business, public policy, or related field preferred
Extensive experience in the pharmaceutical industry, ideally in portfolio risk management, market access, or strategic planning roles
Deep understanding of the US healthcare policy and regulatory landscape; specific knowledge of the IRA is highly valued
Strong leadership skills with proven ability to drive cross-functional teams and lead complex projects
Exceptional communication, negotiation, and interpersonal abilities
Demonstrated analytical thinking and problem-solving skills

Director, Inflation Reduction Act Strategy – Planning

Key skills